Vitae Pharmaceuticals, Inc Contracts & Agreements
42 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (7)
- Human Resources (10)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (8)
- AGREEMENT AND PLAN OF MERGER dated as of September 13, 2016, among ALLERGAN HOLDCO US, INC., AUGUSTA MERGER SUB, INC. and VITAE PHARMACEUTICALS, INC. (Filed With SEC on September 14, 2016)
- Vitae Pharmaceuticals, Inc. Management Cash Incentive Plan (As Amended and restated Effective June 28, 2016) (Filed With SEC on August 4, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2016)
- VITAE PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on June 30, 2016)
- 5,833,333 Shares Vitae Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 24, 2016)
- VITAE PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN (AS ADOPTED ON JULY 23, 2014) (Filed With SEC on March 31, 2015)
- [ ] Shares Vitae Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 20, 2015)
- [Number of Firm Shares] Shares Vitae Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on September 8, 2014)
- VITAE PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN (AS ADOPTED ON JULY 23, 2014) (Filed With SEC on September 8, 2014)
- VITAE PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED PRIOR TO THE INITIAL PUBLIC OFFERING) (Filed With SEC on September 8, 2014)
- VITAE PHARMACEUTICALS, INC. MANAGEMENT CASH INCENTIVE PLAN (AS ADOPTED EFFECTIVE JULY 23, 2014) (Filed With SEC on September 8, 2014)
- Non-Employee Director Compensation Program (Filed With SEC on September 8, 2014)
- VITAE PHARMACEUTICALS, INC. 2001 STOCK PLAN ADOPTED ON DECEMBER 10, 2001 LAST AMENDED AND RESTATED ON JULY 25, 2007 (Filed With SEC on August 28, 2014)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on August 28, 2014)
- VITAE PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT OCTOBER 2, 2007 (Filed With SEC on August 12, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on August 12, 2014)
- VITAE PHARMACEUTICALS, INC. 2001 STOCK PLAN ADOPTED ON DECEMBER 10, 2001 LAST AMENDED AND RESTATED ON JULY 25, 2007 (Filed With SEC on August 12, 2014)
- CONCURRENT PHARMACEUTICALS, INC. 2004 STOCK PLAN ADOPTED ON MAY , 2004 (Filed With SEC on August 12, 2014)
- VITAE PHARMACEUTICALS, INC. 2013 STOCK PLAN ADOPTED ON NOVEMBER 20, 2013 (Filed With SEC on August 12, 2014)
- CONFIDENTIAL TREATMENT REQUESTED RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN VITAE PHARMACEUTICALS, INC. AND BOEHRINGER INGELHEIM INTERNATIONAL GMBH Dated as of October... (Filed With SEC on August 12, 2014)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT AGREEMENT TO THE RESEARCH COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 12, 2014)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT AGREEMENT NO. 2 TO THE RESEARCH COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 12, 2014)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT AGREEMENT NO. 3 TO THE RESEARCH COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 12, 2014)
- CONFIDENTIAL TREATMENT REQUESTED BACE RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN VITAE PHARMACEUTICALS, INC. AND BOEHRINGER INGELHEIM INTERNATIONAL GMBH Dated as of... (Filed With SEC on August 12, 2014)
- CONFIDENTIAL TREATMENT REQUESTED Amendment No. 1 (Filed With SEC on August 12, 2014)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT AGREEMENT NO. 2 TO THE RESEARCH COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 12, 2014)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT AGREEMENT NO. 3 TO THE RESEARCH COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 12, 2014)
- 435 TASSO STREET, SUITE 200 PALO ALTO, CALIFORNIA 94301 PHONE ###-###-#### FAX ###-###-#### (Filed With SEC on August 12, 2014)
- 502 West Office Center Drive Fort Washington, PA 19034 Phone: 215 ###-###-#### Fax: 215 ###-###-#### www.vitaepharma.com (Filed With SEC on August 12, 2014)
- 502 West Office Center Drive Fort Washington, PA 19034 Phone: 215 ###-###-#### Fax: 215 ###-###-#### www.vitaepharma.com (Filed With SEC on August 12, 2014)
- 502 West Office Center Drive Fort Washington, PA 19034 Phone: 215 ###-###-#### Fax: 215 ###-###-#### www.vitaepharma.com Jeffrey S. Hatfield Chief Executive Officer (Filed With SEC on August 12, 2014)
- 502 West Office Center Drive Fort Washington, PA 19034 Phone: 215 ###-###-#### Fax: 215 ###-###-#### www.vitaepharma.com (Filed With SEC on August 12, 2014)
- Vitae Pharmaceuticals, Inc. 502 West Office Center Drive Ft. Washington, PA 19034 April 3, 2006 (Filed With SEC on August 12, 2014)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on August 12, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on August 12, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on August 12, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on August 12, 2014)
- AGREEMENT OF LEASE BETWEEN 502 WOC PROPERTIES, LP AS LANDLORD AND CONCURRENT PHARMACEUTICALS, INC. AS TENANT (Filed With SEC on August 12, 2014)
